Upgrade to SI Premium - Free Trial

Truist Securities Reiterates Buy Rating on Alkermes (ALKS): "remains one of our highest conviction BUY rated stocks"

March 10, 2026 8:24 AM
Truist Securities analyst Joon Lee reiterated a Buy rating and $55.00 price target on Alkermes (NASDAQ: ALKS)The analyst commented, "We ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments